AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20580422 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone 45 mg oral once daily
Number of subjects: 491
Study 18211120 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine at a dose of 2.5 microg/kg/min
Number of subjects: 23
Study 18211120 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine at a dose of 5 microg/kg/min
Number of subjects: 23
Study 18211120 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine at a dose of 10 microg/kg/min
Number of subjects: 23
Study 16630938 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (polymerized extract)
Number of subjects: 60
Study 16630938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12815493 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted intervention
Number of subjects: 1305
Study 12815493 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1305
Study 11483912 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (50 to 100 microg)
Number of subjects: 825
Study 11483912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 825
Study 11483912 — intervention group
Group type: COMPARATOR
Intervention: No intervention (observational group)
Number of subjects: 825
Study 9605363 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score based on patient-related factors (gender, age, smoking status, history of PV or motion sickness, duration of anaesthesia)
Number of subjects: 1137
Study 7847604 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene
Number of subjects: 1
Study 3131904 — intervention group
Group type: EXPERIMENTAL
Intervention: Esberitox
Number of subjects: 50
Study 3131904 — intervention group
Group type: COMPARATOR
Intervention: Control (no Esberitox)
Number of subjects: 50
Study 31848068 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2.0 mA)
Number of subjects: 54
Study 31848068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2.0 mA)
Number of subjects: 54
Study 31848068 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (0.1 mA)
Number of subjects: 54
Study 29623676 — intervention group
Group type: EXPERIMENTAL
Intervention: BRECONDA + usual care
Number of subjects: 222
Study 29623676 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study 28673384 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (TRT) for 24 weeks
Number of subjects: 0
Study 28673384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26330303 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 243
Study 26330303 — intervention group
Group type: EXPERIMENTAL
Intervention: Mainly exercise
Number of subjects: 243
Study 26330303 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 243
Study 23999955 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 556
Study 23999955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 556
Study 21143499 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.5 mg kg(‐1) ideal body weight
Number of subjects: 20
Study 21143499 — intervention group
Group type: COMPARATOR
Intervention: Atracurium 0.5 mg kg(‐1) total body weight
Number of subjects: 20
Study 18332193 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult child's reliance on instrumental support
Number of subjects: 304
Study 18332193 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult child's reliance on expressive support
Number of subjects: 304
Study 16550242 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Meal Intervention (FMI)
Number of subjects: 12
Study 16550242 — intervention group
Group type: COMPARATOR
Intervention: Outpatient family-based therapy (without FMI)
Number of subjects: 12
Study 14584714 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analyses in multiarmed clinical trials
Number of subjects: 0
Study 10750628 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Insulin Treatment (FIT)
Number of subjects: 100
Study 8956374 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patch (21 mg)
Number of subjects: 211
Study 8956374 — intervention group
Group type: COMPARATOR
Intervention: Placebo transdermal patch
Number of subjects: 211
Study 1394752 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (1 mg.kg‐1)
Number of subjects: 90
Study 1394752 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (10 mg.kg‐1)
Number of subjects: 90
Study 1394752 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.1 ml.kg‐1)
Number of subjects: 90
Study 30077043 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher average rating of surgeons
Number of subjects: 250
Study 30077043 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience of surgeons
Number of subjects: 250
Study 30077043 — intervention group
Group type: EXPERIMENTAL
Intervention: Trustworthiness
Number of subjects: 250
Study 30077043 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative comments on professional competence
Number of subjects: 250
Study 30077043 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience match
Number of subjects: 250
Study 29769831 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g Specific Collagen Peptides (SCP)
Number of subjects: 50
Study 29769831 — intervention group
Group type: COMPARATOR
Intervention: 5 g Placebo (Maltodextrin)
Number of subjects: 50
Study 29769831 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up after 3 months
Number of subjects: 50
Study 26811431 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor residual spraying (IRS) with α‐cypermethrin plus standard of care environmental management (SoC‐EM)
Number of subjects: 0
Study 26811431 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-lasting insecticide-treated nets (LLINs) plus standard of care environmental management (SoC‐EM)
Number of subjects: 0
Study 26811431 — intervention group
Group type: COMPARATOR
Intervention: Standard of care environmental management (SoC‐EM)
Number of subjects: 0
Study 24631058 — intervention group
Group type: EXPERIMENTAL
Intervention: Head Elevated Ramped Position
Number of subjects: 60
Study 24631058 — intervention group
Group type: COMPARATOR
Intervention: Control - horizontal with a small pillow under the head
Number of subjects: 60
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-sintered Co-Cr (LS) with Ketac Cem Plus (KC)
Number of subjects: 30
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-cast Pd-Au (CP) with Ketac Cem Plus (KC)
Number of subjects: 30
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-cast Co-Cr (CC) with Ketac Cem Plus (KC)
Number of subjects: 30
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-sintered Co-Cr (LS) with Panavia F 2.0 (PF)
Number of subjects: 30
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-cast Pd-Au (CP) with Panavia F 2.0 (PF)
Number of subjects: 30
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-cast Co-Cr (CC) with Panavia F 2.0 (PF)
Number of subjects: 30
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-sintered Co-Cr (LS) with RelyX Unicem 2 Automix (RXU)
Number of subjects: 30
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-cast Pd-Au (CP) with RelyX Unicem 2 Automix (RXU)
Number of subjects: 30
Study 22108101 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-cast Co-Cr (CC) with RelyX Unicem 2 Automix (RXU)
Number of subjects: 30
Study 21660774 — intervention group
Group type: EXPERIMENTAL
Intervention: First-year student physical activity and action-planning brochure
Number of subjects: 255
Study 21660774 — intervention group
Group type: EXPERIMENTAL
Intervention: Canada's Physical Activity Guide (CPAG)
Number of subjects: 255
Study 21660774 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 255
Study 17561977 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 0
Study 17561977 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 0
Study 16089139 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of Sodium hyaluronate (SH) plus external application of Sanhua ointment (SHO)
Number of subjects: 112
Study 16089139 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection of Sodium hyaluronate (SH)
Number of subjects: 112
Study 12145036 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% saline (NS) solution
Number of subjects: 30
Study 12145036 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's (LR) solution
Number of subjects: 30
Study 9933262 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarct volume measured by operator‐assisted computerized planimetry in patients with visible new supratentorial infarcts (132 patients)
Number of subjects: 191
Study 9933262 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarct volume correlations with clinical outcome scales
Number of subjects: 191
Study 7483543 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrocepine
Number of subjects: 72
Study 7483543 — intervention group
Group type: COMPARATOR
Intervention: H2-blockers
Number of subjects: 72
Study 2249121 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporin antibiotic prophylaxis
Number of subjects: 196
Study 2249121 — intervention group
Group type: COMPARATOR
Intervention: Antiseptic lubricating jelly
Number of subjects: 196
Study 7028069 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with an autologous irradiated suspension of tumour cells combined with a small dose of C. parvum given intradermally during convalescence
Number of subjects: 95
Study 7028069 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-up
Number of subjects: 95
Study 31787389 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple Watch (AW)
Number of subjects: 32
Study 31787389 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit (FB)
Number of subjects: 32
Study 31787389 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices (AW and FB)
Number of subjects: 32
Study 31404850 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE)
Number of subjects: 30
Study 31404850 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 30
Study 28121650 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 167
Study 28121650 — intervention group
Group type: COMPARATOR
Intervention: Clerkships as usual (CAU)
Number of subjects: 167
Study 25291318 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes self-management education plus nurse case management
Number of subjects: 71
Study 25291318 — intervention group
Group type: COMPARATOR
Intervention: Diabetes self-management education only
Number of subjects: 71
Study 23810691 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions (counseling on weight loss, healthy diet, and exercise)
Number of subjects: 481
Study 20946227 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 64
Study 20946227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 18551295 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with 12 mg lutein and 1 mg zeaxanthin once per day (Ocuvite lutein) for 6 months
Number of subjects: 108
Study 18551295 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary supplement)
Number of subjects: 108
Study 17645482 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg b.i.d.
Number of subjects: 52
Study 17645482 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose pantoprazole (80 mg + 8 mg/h)
Number of subjects: 52
Study 17645482 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg q.d.
Number of subjects: 52
Study 15738857 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral therapy (CBT)
Number of subjects: 84
Study 15738857 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help cognitive-behavioral therapy (CBT)
Number of subjects: 84
Study 15738857 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT)
Number of subjects: 84
Study 11158186 — intervention group
Group type: EXPERIMENTAL
Intervention: Marimastat (an orally bioavailable analogue of batimastat)
Number of subjects: 0
Study 11158186 — intervention group
Group type: EXPERIMENTAL
Intervention: Col-3 (a nonantibiotic chemically modified tetracycline)
Number of subjects: 0
Study 11158186 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpeptidic MMP inhibitors
Number of subjects: 0
Study 11158186 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracyclines
Number of subjects: 0
Study 9812649 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvia Miltiorrhiza Composita (SMCo)
Number of subjects: 40
Study 9812649 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SMCo)
Number of subjects: 40
Study 7962442 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigated for antiphospholipid antibodies (APA), polycystic ovaries (PCO), hypersecretion of luteinizing hormone (LH), and chromosome abnormalities.
Number of subjects: 500
Study 7962442 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound diagnosis of PCO
Number of subjects: 500
Study 7962442 — intervention group
Group type: EXPERIMENTAL
Intervention: Early morning urinary LH analysis
Number of subjects: 500
Study 7962442 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for circulating APA
Number of subjects: 500
Study 3311439 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-tablet regimen (500 mg mefloquine, 1000 mg sulfadoxine, 50 mg pyrimethamine)
Number of subjects: 89
Study 3311439 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-tablet regimen (750 mg mefloquine, 1500 mg sulfadoxine, 75 mg pyrimethamine)
Number of subjects: 89
Study 3311439 — intervention group
Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 89
Study 31898521 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA-RIF (oral arsenic realgar-indigo naturalis formula)
Number of subjects: 0
Study 31898521 — intervention group
Group type: COMPARATOR
Intervention: ATRA-ATO (intravenous arsenic trioxide)
Number of subjects: 0
Study 31015214 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training
Number of subjects: 112
Study 31015214 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical use of M‐CPR
Number of subjects: 112
Study 29231432 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with rehabilitation
Number of subjects: 184
Study 29231432 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation (conventional physical training and massage)
Number of subjects: 184
Study 26279077 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.02 mg/kg
Number of subjects: 18
Study 26279077 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (exact dosage not specified for group M1)
Number of subjects: 18
Study 23776445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine administration during memory testing after Pavlovian fear conditioning
Number of subjects: 18
Study 23776445 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration during memory testing after Pavlovian fear conditioning
Number of subjects: 18
Study 23776445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine administration
Number of subjects: 18
Study 23776445 — intervention group
Group type: EXPERIMENTAL
Intervention: Appetitive learning procedure with ketamine
Number of subjects: 18
Study 21484867 — intervention group
Group type: EXPERIMENTAL
Intervention: AFQ056 25-150 mg twice daily for 16 days (study 1)
Number of subjects: 59
Study 21484867 — intervention group
Group type: EXPERIMENTAL
Intervention: AFQ056 25-150 mg twice daily for 16 days (study 2)
Number of subjects: 59
Study 21484867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 21484867 — intervention group
Group type: EXPERIMENTAL
Intervention: AFQ056
Number of subjects: 59
Study 19450052 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic oral anticoagulation (e.g., warfarin or dicoumarol)
Number of subjects: 0
Study 19450052 — intervention group
Group type: COMPARATOR
Intervention: Oral antiplatelet agents
Number of subjects: 0
Study 16410042 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking by parents
Number of subjects: 20
Study 16410042 — intervention group
Group type: COMPARATOR
Intervention: Control care (without facilitated tucking)
Number of subjects: 20
Study 15320653 — intervention group
Group type: EXPERIMENTAL
Intervention: Women soccer players
Number of subjects: 34
Study 15320653 — intervention group
Group type: COMPARATOR
Intervention: Sedentary women
Number of subjects: 34
Study 11240956 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal injection of killed Mycobacterium vaccae (SRL 172)
Number of subjects: 41
Study 11240956 — intervention group
Group type: COMPARATOR
Intervention: Placebo (buffer solution)
Number of subjects: 41
Study 9259191 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (48-hour infusion)
Number of subjects: 194
Study 9259191 — intervention group
Group type: COMPARATOR
Intervention: Isotonic glucose (placebo)
Number of subjects: 194
Study 9259191 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (48-hour infusion) in elderly patients (> 70 years)
Number of subjects: 194
Study 8100345 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU retinol equivalent; 100,000 IU for children under 12 months) every 4 months
Number of subjects: 21906
Study 3544807 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion
Number of subjects: 0
Study 3544807 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical expansion
Number of subjects: 0
Study 31087093 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital behavioral pain medicine intervention (MSS)
Number of subjects: 68
Study 31087093 — intervention group
Group type: COMPARATOR
Intervention: Digital general health education (HE)
Number of subjects: 68
Study 28296750 — intervention group
Group type: EXPERIMENTAL
Intervention: All-arthroscopic (AA) repair
Number of subjects: 100
Study 28296750 — intervention group
Group type: COMPARATOR
Intervention: Mini-open (MO) repair
Number of subjects: 100
Study 25673148 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine-containing medication (25 mg diphenhydramine, 10 mg phenylephrine)
Number of subjects: 22
Study 25673148 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan syrup (30 mg)
Number of subjects: 22
Study 25673148 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 22
Study 24305660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger compress
Number of subjects: 20
Study 24305660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger patch
Number of subjects: 20
Study 21423025 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended daily NVP (ExtNVP) through 14 weeks
Number of subjects: 3126
Study 21423025 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended daily NVP + ZDV (ExtNVP/ZDV) through 14 weeks
Number of subjects: 3126
Study 21423025 — intervention group
Group type: COMPARATOR
Intervention: Control (single-dose nevirapine + 1-week zidovudine)
Number of subjects: 3126
Study 21423025 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended arms (ExtNVP and ExtNVP/ZDV combined)
Number of subjects: 3126
Study 19374309 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower extremity functional exercise (forward step up, lateral step up, heel raise, lunge) for 8 weeks
Number of subjects: 20
Study 19374309 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 20
Study 17563161 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CBT)
Number of subjects: 0
Study 17563161 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant medication (ADM)
Number of subjects: 0
Study 17563161 — intervention group
Group type: EXPERIMENTAL
Intervention: High post acute treatment levels of decentering and low cognitive reactivity
Number of subjects: 0
Study 15334612 — intervention group
Group type: EXPERIMENTAL
Intervention: 9.6 μm TEA CO2 laser (2.4 or 4.8 J delivered for 20 or 40 seconds)
Number of subjects: 24
Study 15334612 — intervention group
Group type: COMPARATOR
Intervention: Sham dental procedure (positive control)
Number of subjects: 24
Study 15334612 — intervention group
Group type: COMPARATOR
Intervention: No procedure (negative control)
Number of subjects: 24
Study 11354586 — intervention group
Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 152
Study 11354586 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact
Number of subjects: 152
Study 11354586 — intervention group
Group type: EXPERIMENTAL
Intervention: Protest
Number of subjects: 152
Study 11354586 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 152
Study 10881755 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week disease-management program ('Women take PRIDE')
Number of subjects: 570
Study 10881755 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 570
Study 7886986 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 4000 (PEG) 60g/d
Number of subjects: 8
Study 2590918 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermia (34 degrees C) with empty beating heart
Number of subjects: 2
Study 2590918 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia (27-33 degrees C) with ventricular fibrillation
Number of subjects: 2
Study 142248 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilidine (100 mg i.m.)
Number of subjects: 99
Study 142248 — intervention group
Group type: COMPARATOR
Intervention: Pethidine (100 mg i.m.)
Number of subjects: 99
Study 142248 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilidine (Valoron)
Number of subjects: 99
Study 142248 — intervention group
Group type: COMPARATOR
Intervention: Pethidine (Dolantin)
Number of subjects: 99
Study 31558161 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational stress measured using the Osipow Occupational Stress Questionnaire
Number of subjects: 155
Study 31558161 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscale of 'Role Overload'
Number of subjects: 155